1Hofbauer LC,Heufelder AE. Osteoprotegerin: A novel local player in bone metabolism [J]. Eur J En docrionl, 1997,137(4): 345～ 346.
2Hofbauer LC,Heufelder AE. Osteoprotegerin and its cognate ligand :A new paradigm of osteoclastogenesis[J]. Eur J Endorcrionl, 1998,139 (2): 152～ 154.
3Aubin JE, Bonnelye E. Osteoprotegerin and its ligand:A new paradigm for regulation of osteoclastogenesis and bone resorption [J]. Osteoporos Int,2000,11(11):905～913.
4Brandstrom H, Jonsson KB, Vidal O et al. Tumor necrosis factor-alpha and beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells [J]. Biochem Biophys Res Commun, 1998,248(3):454～457.
5Bord S,Ireland DC,Beavan SR et al. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts[J]. Bone, 2003,32(2) : 136～141.
6Hofbauer LC,Hicok KC,Chen D et al. Regulation of osteoprotegerin production by androgens and antiandrogens in human osteoblastic lineage cells[J]. Eur J Endocrinol, 2002,147 (2): 269 ～ 273.
7Erben RG,Brunner KS,Breig B et al. Skeletal effects of cyclosporin A are gender related in rats [J]. Endocrinology, 2003,144 (1): 40 ～ 49.
8Ferrini RL, Barrett-Connor E. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in communi ty-dwelling men[J]. Am J Epidemiol, 1998,147 (8):750～754.
9Falahati-Nini A,Riggs BL, Atkinson EJ et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men[J]. J Clin Invest ,2000,106(12): 1553～1560.
10Hofbauer LC,Khosla S,Dunstan CR et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells [J]. Endocrinology, 1999,140 (9): 4367 ～ 4370.
3Mazess RB.Fracture risk:a role for compact bone[J].Calcif Tissue Int,1990,47(4):191-193.
4Riggs BL,Khosla S,Melton LJ 3rd.Sex steroids and the construction and conservation of the adult skeleton[J].Endocr Rev,2002,23(3):279-302.
5Nagai m,Sato N.Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.Biochem Biophys Res Commun,1999,25(7):719-723.
6Kostenuik PJ.Osteoprotegerin and RANKL regulate bone resorption,density,geometry and strength[J].Curr Opin Pharmacol,2005,5(6):618-625.
7Yasuda H.Bone and bone related biochemical examinations.Bone and collagen related metabolites.Receptor activator of NF-kappaB ligand (RANKL)[J].Clin Calcium,2006,16(6):964-970.
8Blair JM,ZhengY,Dunstan C R.RANK ligand[J].Int J Biochem CellBiol,2007,39(6):1077-1081.
9Ikeda T,Kasai M,Suzuki J,et al.Multimerization of the receptor activator of nuclear factor-kappaB ligand(RANKL)isoforms and regulation of osteoclastgenesis[J].Biol Chem,2003,278(47):47217-47222.
10Hsu H,Lacey DL,Dunstan CR,et al.Tumor necrosis factor receptor family member RANK mediates osteoclast diffierentiation and activation induced by osteoprotegerin ligand[J].Proc Natl Acad Sci USA,1999,96(7):3540-3545.
